TAO Synergies Inc. (TAOX)
TAO Synergies Inc. operates in the Software - Application industry of the Technology sector, headquartered in New York, NY, US. The stock last traded at $4.43, down 0.89% on the session, giving a market capitalisation of $33.1M. On trailing twelve-month figures it carries a trailing P/E of -1.11, a net margin of -2155.5%. Its beta of 1.50 implies it has historically moved more than the broad market.
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
TAO Synergies Inc. is most often compared with the following Technology names: